SEMA6A and age-related macular degeneration: Additionally, miR-27expression has been linked to a number of diseases, such as neovascular age-related macular degeneration (AMD), where it has been reported to promote abnormal angiogenesis of the blood vessels behind the eye, by targeting the angiogenesis inhibitors SEMA6A and SPROUTY2 [50], [51].